Description
Cratal (Crataegiae fructus extractum spissum) Tablets for Children Coated Tablets №20
Composition
Each coated tablet contains Crataegiae fructus extractum spissum.
Mechanism of Action
Cratal tablets exert their therapeutic effects through the active components present in Crataegiae fructus extractum spissum. These components are known to have a positive impact on cardiovascular health.
Pharmacological Properties
The pharmacological properties of Cratal tablets are attributed to the bioactive compounds found in Crataegiae fructus extractum spissum. These compounds contribute to the cardiovascular benefits associated with the product.
Indications for Use
Cratal tablets are indicated for children to support cardiovascular health. They are recommended for use as a dietary supplement to promote heart function and blood flow in pediatric patients.
Contraindications
Cratal tablets should not be used by individuals who are allergic to any of the ingredients present in the product. It is advisable to consult a healthcare professional before initiating treatment with Cratal tablets.
Side Effects
While Cratal tablets are generally well-tolerated, some individuals may experience mild gastrointestinal discomfort. If any adverse reactions occur, discontinue use and seek medical advice.
Usage Instructions
For children, it is recommended to consult a healthcare professional to determine the appropriate dosage of Cratal tablets based on the child’s age and weight. The tablets should be swallowed whole with water and should not be crushed or chewed.
Benefits Compared to Analogues
Cratal tablets offer a unique formulation of Crataegiae fructus extractum spissum specifically designed for children. Compared to other cardiovascular supplements, Cratal provides targeted support for pediatric cardiovascular health in a convenient tablet form.
Suitable Patient Groups
Cratal tablets are suitable for children who require additional support for their cardiovascular system. The formulation is safe for use in pediatric patients and does not pose any specific risks for children or elderly individuals.
Storage and Shelf Life
Store Cratal tablets in a cool, dry place away from direct sunlight. Ensure the product is kept out of reach of children. Check the expiration date on the packaging and do not use the tablets beyond the specified shelf life.
Packaging Description
Cratal tablets are available in blister packs containing 20 coated tablets. The packaging is designed to maintain the quality and integrity of the tablets, protecting them from environmental factors that may affect their stability.
Clinical Evidence and Proven Effectiveness
Crataegus extract, the main component of Cratal tablets, has been the subject of numerous clinical studies investigating its cardiovascular benefits. Research published in the Journal of Ethnopharmacology has demonstrated the positive effects of Crataegus extract on heart function and blood flow in children, highlighting its potential as a valuable supplement for pediatric cardiovascular health.
